[1]
Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020. [Epub ahead of print]
[http://dx.doi.org/10.1001/jamaneurol.2020.1127] [PMID: 32275288]
[http://dx.doi.org/10.1001/jamaneurol.2020.1127] [PMID: 32275288]
[2]
Guan W, Ni Z, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-20.https://www.nejm.org/doi/full/10.1056/NEJMoa2002032
[3]
Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020; 367(6483): 1260-3.
[http://dx.doi.org/10.1126/science.abb2507] [PMID: 32075877]
[http://dx.doi.org/10.1126/science.abb2507] [PMID: 32075877]
[4]
Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008; 82(15): 7264-75.
[http://dx.doi.org/10.1128/JVI.00737-08] [PMID: 18495771]
[http://dx.doi.org/10.1128/JVI.00737-08] [PMID: 18495771]
[5]
Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020; 11(7): 995-8.
[http://dx.doi.org/10.1021/acschemneuro.0c00122] [PMID: 32167747]
[http://dx.doi.org/10.1021/acschemneuro.0c00122] [PMID: 32167747]
[6]
Alzforum. Coronavirus takes its toll on Alzheimer’s clinical studies. Alzforum 2020. Available from:
https://www.alzforum.org/news/community-news/coronavirus-takes-its-toll-alzheimers-clinical-studies
[7]
Alzforum. A ‘Perfect Storm’ for families grappling with dementia. Alzforum 2020. Available from:
https://www.alzforum.org/ news/ community-news/perfect-storm-families-grappling-dementia
[8]
Editorial. Alzheimer’s disease research enterprise in the era of COVID-19/SARS-CoV-2. Alzheimers Dement 2020; 16(4): 587-8.https://pubmed.ncbi.nlm.nih.gov/32202041/
[9]
Hunsberger JG, Newton SS, Bennett AH, et al. Antidepressant actions of the exercise-regulated gene VGF. Nat Med 2007; 13(12): 1476-82.
[http://dx.doi.org/10.1038/nm1669] [PMID: 18059283]
[http://dx.doi.org/10.1038/nm1669] [PMID: 18059283]
[10]
Lin T-W, Shih Y-H, Chen S-J, et al. Running exercise delays neurodegeneration in amygdala and hippocampus of Alzheimer’s disease (APP/PS1) transgenic mice. Neurobiol Learn Mem 2015; 118: 189-97.
[http://dx.doi.org/10.1016/j.nlm.2014.12.005] [PMID: 25543023]
[http://dx.doi.org/10.1016/j.nlm.2014.12.005] [PMID: 25543023]
[11]
Alzforum. Topline result for first DIAN-TU clinical trial: Negative on primary 2020. Alzforum 2020. Available from:
https://www.alzforum.org/news/research-news/toplineresult-first-dian-tu-clinical-trial-negative-primary
[12]
Shi J, Wen Z, Zhong G, et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science 2020; 368(6494): 1016-20.
[http://dx.doi.org/10.1126/science.abb7015] [PMID: 32269068]
[http://dx.doi.org/10.1126/science.abb7015] [PMID: 32269068]
[13]
Association As 2020. Alzheimer’s disease facts and figures. Alzheimers Dement 2020. Epub ahead of print
[PMID: 32157811]
[PMID: 32157811]
Related Books
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research-Dementia
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Article Metrics
50
1